Skip to main content

Newsroom

Welcome to Blood Cancer United Newsroom 

Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.

label

Patient Education Webcasts

What’s Next on the Roadmap: Finding Primary Care

Join us for a panel discussion on transitioning to primary care after a cancer diagnosis. Transitioning from the oncologist to a primary care provider…

label

Research

BioInvent Receives FDA Orphan Drug Designation for BI-1808 for the Treatment of T-cell Lymphoma

Lund, Sweden – March 20, 2025 – BioInvent International AB (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of nov…

label

Research

Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline

Paris, March 20, 2025. Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under w…

label

Patient Education Webcasts

The Future of Myeloma Treatment: What’s Next?

label

Patient Education Videos

CAR T-Cell Therapy: A Path of Hope and Healing

This new docuseries informs blood cancer patients, caregivers, healthcare providers, and the public about the revolutionary progress of CAR T-cell the…

label

Professional Education Webcasts

Introducción al cáncer de la sangre: Aspectos básicos sobre la enfermedad, el tratamiento y el rol del profesional médico

This is the Spanish translation of Blood Cancer 101: The Basics on Disease, Treatment, and the Role of the HCP.Para trabajadores sociales, enfermeros …

label

Research

Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs

SAN DIEGO, Feb. 05, 2025 - Kura Oncology, Inc. and Kyowa Kirin Co., Ltd. today announced positive topline results from KOMET-001, the Phase 2 registra…

label

Research

BioInvent announces promising initial efficacy data from triple combination arm of BI-1206, rituximab and Calquence for the treatment of non-Hodgkin's lymphoma

Lund, Sweden – January 8, 2025 – BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and dev…

label

Patient Education Webcasts

Cafecito con LLS: Hablemos de Abogacía Legal y Atención Medica

Únase a la conversación donde conocemos a Melanie Grant Esq, abogada de Triage Cancer® defensora jurídica de los derechos de salud para aquellos padec…

label

Professional Education Webcasts

Blood Cancer 101: The Basics on Disease, Treatment, and the Role of the HCP

This activity is intended for oncology social workers, psychologists, nurses, and other healthcare professionals involved in the care of patients with…

For all media-related inquiries and interview requests please email

[email protected]

A Blood Cancer United representative will respond as soon as possible.

We are Blood Cancer United.

Everyone affected by blood cancer—patients, survivors, caregivers, researchers, advocates, fundraisers, everyone—has a story. Share yours.

Grace

Lymphoma Survivor

Greenberger et al. 2022. Blood Cancer Disc. T cell response and 3rd serological response.mRNA vaccine

Ellie

Leukemia survivor

photo of Patagonia

Shayne

Leukemia survivor

photo of Mount Killimanjaro

Matthew

Lymphoma & Leukemia Survivor

Survivor Latasha wearing bright yellow jacket, smiling

Latasha

Leukemia Survivor

Fast Company Brands That Matter 2022 Logo

Chase

Leukemia Survivor

Headshot of Chuck Pagano, Indianapolis Colts Head Coach

Chuck

Leukemia Survivor

Myeloma Link logo lock 10.26.22

Judy

chronic myeloid leukemia (CML)

Deanna

ALL Survivor

Cover - Teens Magazine

Donna

In memory

image of Shushan

Payton

Survivor

 

Brian

ALL Survivor

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.